🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 17 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
14/05/2008 9,60 9,78 9,12 9,24 -3,14% 6,88% 37.733
13/05/2008 10,08 10,08 9,18 9,54 -1,85% 8,93% 56.283
12/05/2008 9,42 9,90 9,06 9,72 +4,52% 8,92% 66.350
09/05/2008 9,00 9,36 8,76 9,30 +6,16% 6,67% 80.283
08/05/2008 8,16 8,88 8,10 8,76 +9,77% 9,56% 49.300
07/05/2008 7,62 8,10 7,56 7,98 +3,91% 7,09% 40.300
06/05/2008 8,34 8,34 7,56 7,68 -8,57% 9,35% 64.650
05/05/2008 8,82 8,88 8,28 8,40 -5,41% 6,80% 32.083
02/05/2008 9,06 9,36 8,76 8,88 -0,67% 6,62% 8.867
01/05/2008 8,94 9,00 8,76 8,94 -0,67% 2,68% 9.650
30/04/2008 9,12 9,12 8,76 9,00 +0,67% 3,95% 16.733
29/04/2008 8,82 9,06 8,70 8,94 -0,67% 4,08% 6.617
28/04/2008 9,00 9,12 8,70 9,00 +0,00% 4,67% 30.233
25/04/2008 9,12 9,12 8,88 9,00 -1,32% 2,63% 11.817
24/04/2008 9,00 9,30 8,82 9,12 -0,65% 5,33% 29.517
23/04/2008 8,94 9,18 8,70 9,18 +4,08% 5,37% 40.083
22/04/2008 9,06 9,24 8,82 8,82 -3,92% 4,64% 30.383
21/04/2008 9,66 9,84 9,18 9,18 -7,27% 6,83% 38.050
18/04/2008 10,20 10,44 9,48 9,90 -1,79% 9,41% 53.217
17/04/2008 9,30 10,14 9,12 10,08 +12,00% 10,97% 68.033
16/04/2008 8,70 9,18 8,70 9,00 +2,74% 5,52% 58.133
15/04/2008 9,48 9,54 8,58 8,76 -7,59% 10,13% 48.283
14/04/2008 9,72 9,90 9,30 9,48 -4,24% 6,17% 20.567
11/04/2008 10,26 10,32 9,66 9,90 -3,51% 6,43% 51.667
10/04/2008 10,26 10,38 9,96 10,26 -1,72% 4,09% 35.000
09/04/2008 10,20 10,68 10,14 10,44 +1,16% 5,29% 32.417
08/04/2008 10,86 10,86 10,26 10,32 -5,49% 5,52% 35.600
07/04/2008 11,52 11,52 10,38 10,92 -3,19% 9,90% 66.950
04/04/2008 11,40 11,52 10,98 11,28 +0,53% 4,74% 62.750
03/04/2008 11,04 11,82 11,04 11,22 +1,08% 7,07% 102.283